PNC Financial Services Group
VIR icon

PNC Financial Services Group’s Vir Biotechnology VIR Stock Holding History

PNC Financial Services Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
10,852
-488
-4% -$4.64K ﹤0.01% 2854
2026
Q1 		$102K Buy
11,340
+918
+9% +$7.32K ﹤0.01% 2809
2025
Q4 		$62.8K Sell
10,422
-2,421
-19% -$14.4K ﹤0.01% 3082
2025
Q3 		$73.3K Sell
12,843
-316
-2% -$1.62K ﹤0.01% 2992
2025
Q2 		$66.3K Buy
13,159
+2,700
+26% +$14.5K ﹤0.01% 2955
2025
Q1 		$67.8K Buy
10,459
+2,171
+26% +$19.3K ﹤0.01% 2915
2024
Q4 		$60.8K Buy
8,288
+1,999
+32% +$15.8K ﹤0.01% 2982
2024
Q3 		$47.1K Sell
6,289
-3,430
-35% -$29.8K ﹤0.01% 3126
2024
Q2 		$86.5K Sell
9,719
-5,239
-35% -$50.2K ﹤0.01% 2710
2024
Q1 		$152K Buy
14,958
+3,772
+34% +$38.4K ﹤0.01% 2364
2023
Q4 		$113K Buy
11,186
+1,869
+20% +$17.1K ﹤0.01% 2527
2023
Q3 		$87.3K Buy
9,317
+4,656
+100% +$66.4K ﹤0.01% 2656
2023
Q2 		$114K Buy
4,661
+640
+16% +$16.1K ﹤0.01% 2566
2023
Q1 		$93.6K Buy
4,021
+13
+0.3% +$332 ﹤0.01% 2611
2022
Q4 		$101K Buy
4,008
+2,937
+274% +$72K ﹤0.01% 2550
2022
Q3 		$20K Sell
1,071
-3,362
-76% -$85.5K ﹤0.01% 3458
2022
Q2 		$114K Buy
+4,433
New +$103K ﹤0.01% 2477
2020
Q4 		– Sell
-26
Closed -$1K – 4074
2020
Q3 		$1K Buy
+26
New +$1.12K ﹤0.01% 3886
2020
Q2 		– Sell
-216
Closed -$8K – 4065
2020
Q1 		$8K Buy
+216
New +$5.81K ﹤0.01% 3493

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PNC Financial Services Group's VIR Position: Q2 2026 in Review

PNC Financial Services Group reduced its Vir Biotechnology (VIR) stake by 4.3% in Q2 2026, selling an estimated $4.64K and leaving 10,852 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

PNC Financial Services Group first reported a position in VIR in Q1 2020 and has held it in 19 quarters since. The position peaked at $152K in Q1 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • PNC Financial Services Group held 10,852 shares of Vir Biotechnology worth $111K as of Q2 2026.
  • PNC Financial Services Group sold 488 Vir Biotechnology shares in Q2 2026, an estimated $4.64K.
  • Vir Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2854 holding.
  • PNC Financial Services Group first reported a position in Vir Biotechnology in Q1 2020 and has held it in 19 quarters since.
  • PNC Financial Services Group's Vir Biotechnology position peaked at $152K in Q1 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.